21714-23-8

Basic information

• Product Name: Cyanamide, (2,6-dichlorophenyl)-
• CAS NO: 21714-23-8
• Molecular Formula: C7H4Cl2N2
• Molecular Weight: 187.028
• Mol File: 21714-23-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Cyanamide, (2,6-dichlorophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyanamide, (2,6-dichlorophenyl)-(21714-23-8)
• EPA Substance Registry System: Cyanamide, (2,6-dichlorophenyl)-(21714-23-8)

Safety Data

• Hazardous Substances Data: 21714-23-8(Hazardous Substances Data)

Upstream product

• 506-68-3 bromocyane 
• 608-31-1 2,6-Dichloroaniline 
• 6590-91-6 1-(2,6-dichlorophenyl)thiourea 

Downstream Products

• 39075-78-0 2.6-Dichlorophenylguanidin 
• 731858-90-5 N-(2,6-dichlorophenyl)-N'-(2-methyl-[1,3]dioxolan-2-ylmethyl)-guanidine trifluoroacetate 
• 731858-93-8 (2,6-dichlorophenyl)-methyl-cyanamide 
• 731858-92-7 N-(2,6-dichlorophenyl)-N'-(1,4-dioxa-spiro[4,5]dec-6-yl)-guanidine 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS

The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of mucositis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of mucus diseases related to painful inflammation and ulceration of the digestive tract lining and in the mouth.

Novel 2,6-disubstituted phenyl-aminoguanidine compounds

The invention relates to compounds of the general formula: EQU1 in which one double bond is present between the carbon atom of the guanidine moiety and one of the adjacent nitrogen atoms and R0 stands for hydrogen, halogen, hydroxy, alkoxy or alkyl (1 to 6 C), R1, r2 for halogen, hydroxy, alkyl (1 to 4 C) or alkoxy (1 to 4 C), R3, r3 ', r3 " for hydrogen or alkyl (1 to 4 C) on the understanding that one of the substituents R3, R3 ' or R3 " is absent because of the presence of the double bond, R4 for hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C) or amino optionally substituted with one or two alkyl (1 to 4 C) groups, R5, r6 for hydrogen, alkyl (1-6 C), acyl or R5 + R6 together represent an alkylidene, cyclic alklidene or aralkylidene group, As well as the acid addition salts thereof, provided that, if R4 stands for methyl and R0, R3, R3 ", R5 and R6 for hydrogen, R1 and R2 may not represent methyl simultaneously, having a strong and long-acting anti-hypertensive activity.